Syndicate Bio’s Cancer Genome Nigeria study and comprehensive genomics profiling tests for clinical oncology

Syndicate Bio shared on LinkedIn:

“Throwback to when we hosted the National Institute for Cancer Research and Treatment (NICRAT) leadership, led by Professor Usman Aliyu and Dr. Waziri, at our cancer genomics laboratory in Lagos.

This visit to view our genomics profiling capabilities marked a crucial step in our partnership as we prepare for the recruitment phase of the Cancer Genome Nigeria (CGN) study— aimed at uncovering the genetic drivers of Nigeria’s most prevalent cancers.

In addition to CGN, we will be unveiling our suite of comprehensive genomics profiling tests for clinical oncology in a few weeks. These initiatives signify an exciting period for us, promising improved early detection and personalized treatment strategies for Nigerian patients.

For the latest on our genomics profiling test offerings, follow us on Instagram.

To learn about our commitment to advancing precision medicine and improving cancer care across Africa, visit us at www.syndicate.bio.”

Source: Syndicate Bio/LinkedIn